CENTER FOR VALVE DISORDERS
Center for Valve Disorders Physician Team
( FY18 )
James Choi , MD , FACC , FSCAI Baron Hamman , MD Albert Carl Henry III , MD , FACS Haojie Wang , MD , PhD , FACC , RPVI Maninder Kaur , RN , MS , APRN , ANP-BC Paul A . Grayburn , MD , FACC Aldo Rafael , MD Stuart R . Lander , MD , FACC Robert C . Stoler , MD , FACC , FSCAI Ravi C . Vallabhan , MD , FACC , FSCAI Robert F . Hebeler , Jr ., MD , FACS
Minimally Invasive Mitral Valve Therapies
For years , open heart surgery was the only treatment option for mitral regurgitation – when the heart ’ s mitral valve doesn ’ t close tightly , allowing blood to flow backward into the heart . Through the advancement of research and the clinical trials conducted by cardiologists on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas , mitral regurgitation can be treated using devices placed through a small incision in the groin .
RESEARCH TRIALS
• Abbott COAPT Continued Access ( CAS ) — MitraClip ® repair for patients with functional severe mitral regurgitation and heart failure on optimal guideline-directed medical management
• Abbott Tendyne — Transcatheter mitral valve replacement
• Apollo — Medtronic Intrepid™ Trial for severe mitral regurgitation
Minimally Invasive Mitral Valve Repair In-Hospital Mortality Rate
( FY18 )
Femoral Access in Minimally Invasive Mitral Valve Repair Patients
( FY18 )
0 % 100 %
The Dallas team is one of the highest volume sites using MitraClip ® and was involved in its initial trial , the COAPT Trial , which led to the evolution of this device .
39